Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling

Jiali Wan(Wuhan University), W Li(Wuhan University)
British Journal of Cancer
June 27, 2013
Cited by 96


Related Papers